Plasma homocysteine and the severity of heart failure in patients with previous myocardial infarction.
Journal Title: Cardiology Journal - Year 2011, Vol 18, Issue 1
Abstract
Homocysteine is considered to be a risk factor, or an indicator of risk, for the development of cardiovascular disease. Little data is available on its significance in patients with previous myocardial infarction. The aim of our study was to assess the plasma level of homocysteine and its relationship with the severity of heart failure in patients with chronic myocardial infarction.
Authors and Affiliations
Lucia Agoston-Coldea, Teodora Mocan, Marc Gatfosse, Silvia Lupu, Dan L Dumitrascu
Access strategies for peripheral arterial intervention.
An operator's ability to determine the optimal vascular access strategy for patients undergoing peripheral endovascular intervention is critical to maximizing procedural safety and success. Individualizing an approach to...
Congenital left main coronary artery aneurysm.
Left main coronary artery aneurysm (LMCAA) is an uncommon coronary abnormality seen in 0.1% of patients during routine diagnostic coronary angiographies. The most common etiology is atherosclerosis in acquired cases. How...
Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
Dual antiplatelet therapy is currently recommended for all patients with acute coronary syndromes, independent of whether they receive pharmacological treatment or undergo percutaneous coronary intervention. Antiplatelet...
Radial artery cardiac catheterization: changing the convincing data/work to change (CD/WC) ratio.
Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
Adult patients with congenital heart disease (CHD) usually find their exercise capacity satisfactory. However, objective evaluation is important for diagnostic and prognostic purposes. The aim of this study was to evalua...